Stryker SYK
NYSE SYK
$339.12 -0.86 (-0.25%)
At close: Aug 20, 2026 · 12:14 PM UTC

Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026)

Stryker (SYK) posted quarterly Liabilities and Shareholders Equity of $47.9 billion for Q2 2026, up 56959.52% year-over-year from N/an in Q2 2025, and up 3.54% on a QoQ basis from $46.3 billion in Q1 2026.

Stryker (SYK) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Stryker has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $47.9 billion in Q2 2026.

  • Liabilities and Shareholders Equity for Q2 2026 came in at $47.9 billion, up 56959.52% year-over-year; the trailing twelve-month figure through Jun 2026 was $189.1 billion (up 338.14% YoY), and the FY2025 annual result was $47.8 billion, up 11.34% from the prior year.
  • Liabilities and Shareholders Equity grew to $47.9 billion in Q2 2026, from $46.3 billion in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $47.9 billion in Q2 2026 and troughed at $1.0 million in Q3 2023.
  • A 5-year average of $27.3 billion and a median of $36.5 billion in 2022 frame the typical range for Liabilities and Shareholders Equity.
  • The widest annual swing landed in 2023, when Liabilities and Shareholders Equity sank 100.0%; it then soared 180888.46% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $36.9 billion in 2022, then grew by 8.21% to $39.9 billion in 2023, then climbed by 7.66% to $43.0 billion in 2024, then advanced by 11.34% to $47.8 billion in 2025, then increased by 0.18% to $47.9 billion in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $47.9 billion in Q2 2026, $46.3 billion in Q1 2026, and $47.8 billion in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 200.51 Bn 194.91 Bn 7.27 Bn 109.22 Bn
2 Stryker 129.96 Bn 126.48 Bn 4.50 Bn 47.93 Bn
3 Medtronic 120.18 Bn 110.96 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 74.28 Bn 73.74 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 52.75 Bn 48.50 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.67 Bn 32.73 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 34.23 Bn 32.12 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.46 Bn 23.14 Bn 4.55 Bn 31.04 Bn
9 Steris 23.30 Bn 22.82 Bn 684.20 Mn 10.74 Bn
10 Zimmer Biomet Holdings 19.38 Bn 18.97 Bn 1.54 Bn 22.80 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 47.93 Bn
Mar 31, 2026 46.29 Bn
Dec 31, 2025 47.84 Bn
Sep 30, 2025 47.06 Bn
Jun 30, 2025 46.33 Bn
Mar 31, 2025 84.00 Mn
Dec 31, 2024 42.97 Bn
Sep 30, 2024 26.00 Mn
Jun 30, 2024 26.00 Mn
Mar 31, 2024 26.00 Mn
Dec 31, 2023 39.91 Bn
Sep 30, 2023 1.00 Mn
Jun 30, 2023 37.41 Bn
Mar 31, 2023 36.83 Bn
Dec 31, 2022 36.88 Bn
Sep 30, 2022 35.98 Bn
Jun 30, 2022 36.03 Bn
Mar 31, 2022 36.14 Bn
Dec 31, 2021 34.63 Bn
Sep 30, 2021 34.15 Bn